Quart Barry D
- SEC CIK
- 0001384243
In the past year, 5 open-market sale filings worth $2.68M and no purchases.
Current role at each company
- KNSA Kiniksa Pharmaceuticals International, plcDirectoras of Aug 21, 2026
- HRTX Heron Therapeutics, Inc.Chief Executive Officeras of Jan 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.68M
- 5 filings
- Net
- −$2.68M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Quart Barry D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KNSA Kiniksa Pharmaceuticals International, plc
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 (view filing) | Apr 28 | 1 day | Quart Barry DDirector | SSaleClass A Ordinary Share | −13.1K | $50.10 | −$656.3K | −51.1%12.5K after | 10b5-1 |
| Apr 8, 2026 (view filing) | Apr 6 | 2 days | Quart Barry DDirector | SSaleClass A Ordinary Share | −6.90K | $50.00 | −$345.1K | −35.5%12.5K after | 10b5-1 |
| Feb 12, 2026 (view filing) | Feb 10-12 | 2 days | Quart Barry DDirector | SSaleClass A Ordinary Share | −2.80K | $45.00 | −$126.0K | −18.2%12.5K after | 2 lots10b5-1 |
| Feb 4, 2026 (view filing) | Feb 2-4 | 2 days | Quart Barry DDirector | SSaleClass A Ordinary Share | −16.0K | $45.22 | −$721.6K | −56.0%12.5K after | 3 lots10b5-1 |
| Dec 17, 2025 (view filing) | Dec 15 | 2 days | Quart Barry DDirector | SSaleClass A Ordinary Share | −20.1K | $41.51 | −$835.6K | −61.6%12.5K after | 10b5-1 |
| Jun 11, 2025 (view filing) | Jun 9-11 | 2 days | Quart Barry DDirector | SSaleClass A Ordinary Share | −27.4K | $30.35 | −$833.0K | −68.6%12.5K after | 3 lots |
| Dec 1, 2022 (view filing) | Nov 29 | 2 days | Quart Barry DDirector | SSaleClass A Common Share | −22.0K | $16.15 | −$354.6K | −100.0%0 after |